DocDollars

Eisai Inc.

NJ · United States · Reporting entity ID 100000000136

Total reported 2019–2025
$475.2M
#38 of 2,960 reporting companies — 0.6% of all reported industry payments
$70.8M in general payments across 317,723 records, plus $404.4M in research funding across 75,233 records.

How it breaks down

General payments $70,764,798
Research funding $404,389,717

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Eisai Inc. reported $475.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #38 of 2,960 reporting companies. 85% of that was research funding and 15% general payments such as consulting, speaking, food and travel. 317,723 general payment records and 75,233 research records were filed.

Common questions about Eisai Inc.

How much has Eisai Inc. paid US doctors?

Eisai Inc. reported $475,154,515 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $70,764,798 in general payments, $404,389,717 in research funding.

How does Eisai Inc. rank among drug and device companies?

It ranks #38 of 2,960 reporting entities by total reported value, about 0.6% of all industry payments in the dataset.

Does a payment from Eisai Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.